Aptevo Therapeutics Inc

APVONASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

1.42M

on 2026-06-30, from 51 on 2024-03-31 10-Q ↗

Earlier counts are adjusted for three reverse splits; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$100.0M

S-3 of 2025-02-14. 2 prospectus supplements filed under it since. S-3 ↗

$8.0M

Agreement of 2025-06-20. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

730K

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

1.5 quarters

$9.8M on 2026-06-30 ÷ $6.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-08-13	Private placement incl. 0.86M pre-funded	1,723,416	$4.03	not stated	8-K ↗
2026-05-27	Private placement	53,201	$5.075	not stated	8-K ↗
2025-06-30	Registered direct offering	not read	not read	$2.1M	8-K ↗
2025-06-18	Registered direct offering incl. 0.36M pre-funded	2,465,000	$3.25	$8.0M	424B4 ↗
2025-04-21	Registered direct offering	2,324,000	$0.86	$2.0M	424B4 ↗
2025-04-21	Registered direct offering	not read	$0.862	not read	8-K ↗
2025-04-03	Registered direct offering	1,764,710	$1.19	$2.1M	424B4 ↗
2025-04-03	Registered direct offering	3,529,420	not read	not read	8-K ↗

Also on file: a 1-for-6 reverse split, 2025-05-23 8-K ↗ · a 1-for-6 reverse split, 2025-12-29 8-K ↗